Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Blood Cancer Journal, Published online: 04 September 2020; doi:10.1038/s41408-020-00357-4Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 4, 2020 Category: Hematology Authors: Meletios A. Dimopoulos Sagar Lonial Darrell White Philippe Moreau Katja Weisel Jesus San-Miguel Ofer Shpilberg Sebastian Grosicki Ivan Špička Adam Walter-Croneck Hila Magen Maria-Victoria Mateos Andrew Belch Donna Reece Meral Beksac Andrew Spencer Heath Source Type: research

Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis
Blood Cancer Journal, Published online: 01 September 2020; doi:10.1038/s41408-020-00354-7Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 1, 2020 Category: Hematology Authors: Shayna Sarosiek Luke Zheng J. Mark Sloan Karen Quillen Dina Brauneis Vaishali Sanchorawala Source Type: research

Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms
Blood Cancer Journal, Published online: 01 September 2020; doi:10.1038/s41408-020-00356-5Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 1, 2020 Category: Hematology Authors: Matteo Giaccherini Angelica Macauda Nicola Sgherza Juan Sainz Federica Gemignani Jos è Manuel Sanchez Maldonado Manuel Jurado Francesca Tavano Grzegorz Mazur Andr és Jerez Joanna G óra-Tybor Aleksandra Go łos Francisca Hern ández Mohedo Joaquin Marti Source Type: research

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
Blood Cancer Journal, Published online: 01 September 2020; doi:10.1038/s41408-020-00355-6Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 1, 2020 Category: Hematology Authors: Paolo Milani Marco Basset Mario Nuvolone Francesca Benigna Lara Rodigari Francesca Lavatelli Andrea Foli Giampaolo Merlini Giovanni Palladini Source Type: research

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma
Blood Cancer Journal, Published online: 28 August 2020; doi:10.1038/s41408-020-00353-8Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 28, 2020 Category: Hematology Authors: Ashley Paquin Alissa Visram Shaji K. Kumar Morie A. Gertz Hafsa Cantwell Francis K. Buadi Martha Q. Lacy Angela Dispenzieri David Dingli Lisa Hwa Amie Fonder Miriam Hobbs Suzanne R. Hayman John A. Lust Stephen J. Russell Nelson Leung Prashant Kapoor Ronal Source Type: research

Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
Blood Cancer Journal, Published online: 26 August 2020; doi:10.1038/s41408-020-00351-wClinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 26, 2020 Category: Hematology Authors: Wen Shuai Pei Lin Paolo Strati Keyur P. Patel Mark J. Routbort Shimin Hu Peng Wei Joseph D. Khoury M. James You Sanam Loghavi Zhenya Tang Hong Fang Beenu Thakral L. Jeffrey Medeiros Wei Wang Source Type: research

Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells
Blood Cancer Journal, Published online: 25 August 2020; doi:10.1038/s41408-020-00352-9Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 25, 2020 Category: Hematology Authors: Serena Travaglini Daniela Francesca Angelini Valentina Alfonso Gisella Guerrera Serena Lavorgna Mariadomenica Divona Anna Maria Nardozza Maria Irno Consalvo Emiliano Fabiani Marco De Bardi Benedetta Neri Fabio Forghieri Francesco Marchesi Giovangiacinto P Source Type: research

Immune-based therapies in the management of multiple myeloma
Blood Cancer Journal, Published online: 22 August 2020; doi:10.1038/s41408-020-00350-xImmune-based therapies in the management of multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 22, 2020 Category: Hematology Authors: Saurabh Zanwar Bharat Nandakumar Shaji Kumar Source Type: research

Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre
Blood Cancer Journal, Published online: 14 August 2020; doi:10.1038/s41408-020-00349-4Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 14, 2020 Category: Hematology Authors: Huijun Huang Changlu Xu Jie Gao Bing Li Tiejun Qin Zefeng Xu Sirui Ren Yudi Zhang Meng Jiao Shiqiang Qu Lijuan Pan Naibo Hu Jinqin Liu Wenyu Cai Yingnan Zhang Dan Wu Peihong Zhang Robert Peter Gale Gang Huang Jiaxi Zhou Lihong Shi Zhijian Xiao Source Type: research

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response
Blood Cancer Journal, Published online: 11 August 2020; doi:10.1038/s41408-020-00348-5Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 11, 2020 Category: Hematology Authors: Nadine Abdallah S. Vincent Rajkumar Patricia Greipp Prashant Kapoor Morie A. Gertz Angela Dispenzieri Linda B. Baughn Martha Q. Lacy Suzanne R. Hayman Francis K. Buadi David Dingli Ronald S. Go Yi L. Hwa Amie Fonder Miriam Hobbs Yi Lin Nelson Leung Taxiar Source Type: research

Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden
This study involved people with ALL whose cancer had returned after, or stopped responding to, previous treatment. These people received either inotuzumab ozogamicin (InO for short) or standard chemotherapy. Researchers divided people into groups, based on the level of lymphoblast cells they had in their bone marrow (called disease burden): low, medium, or high disease burden. In this study, compared with people who received standard chemotherapy, people who received InO were more likely to have no signs of their cancer (called remission), live to the end of the study, and/or reach the end of the study without their cancer...
Source: Blood Cancer Journal - August 7, 2020 Category: Hematology Authors: Daniel J. DeAngelo Anjali S. Advani David I. Marks Matthias Stelljes Michaela Liedtke Wendy Stock Nicola G ökbuget Elias Jabbour Akil Merchant Tao Wang Erik Vandendries Alexander Neuhof Hagop Kantarjian Susan O ’Brien Source Type: research

Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis
Blood Cancer Journal, Published online: 07 August 2020; doi:10.1038/s41408-020-00347-6Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 7, 2020 Category: Hematology Authors: Benjamin A. Derman Jagoda Jasielec Spencer S. Langerman Wei Zhang Andrzej J. Jakubowiak Brian C.-H. Chiu Source Type: research

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
Blood Cancer Journal, Published online: 05 August 2020; doi:10.1038/s41408-020-00346-7Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 5, 2020 Category: Hematology Authors: Kitsada Wudhikarn M. Lia Palomba Martina Pennisi Marta Garcia-Recio Jessica R. Flynn Sean M. Devlin Aishat Afuye Mari Lynne Silverberg Molly A. Maloy Gunjan L. Shah Michael Scordo Parastoo B. Dahi Craig S. Sauter Connie L. Batlevi Bianca D. Santomasso Ele Source Type: research

In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma
Blood Cancer Journal, Published online: 28 July 2020; doi:10.1038/s41408-020-00344-9In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 28, 2020 Category: Hematology Authors: Amit Kumar Mitra Harish Kumar Vijay Ramakrishnan Li Chen Linda Baughn Shaji Kumar S. Vincent Rajkumar Brian G. Van Ness Source Type: research

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
Blood Cancer Journal, Published online: 24 July 2020; doi:10.1038/s41408-020-00342-xBlinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 24, 2020 Category: Hematology Authors: Franco Locatelli Gerhard Zugmaier Noemi Mergen Peter Bader Sima Jeha Paul-Gerhardt Schlegel Jean-Pierre Bourquin Rupert Handgretinger Benoit Brethon Claudia Rossig Christiane Chen-Santel Source Type: research

Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment
Blood Cancer Journal, Published online: 22 July 2020; doi:10.1038/s41408-020-00343-wBaseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 22, 2020 Category: Hematology Authors: Malin Hultcrantz Even Holth Rustad Venkata Yellapantula Maria Arcila Caleb Ho Mustafa H. Syed Elli Papaemmanuil Yanming Zhang Francesco Maura Ola Landgren Source Type: research

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
Blood Cancer Journal, Published online: 17 July 2020; doi:10.1038/s41408-020-00340-zFollicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 17, 2020 Category: Hematology Authors: Connie L. Batlevi Fushen Sha Anna Alperovich Ai Ni Katy Smith Zhitao Ying Jacob D. Soumerai Philip C. Caron Lorenzo Falchi Audrey Hamilton Paul A. Hamlin Steven M. Horwitz Erel Joffe Anita Kumar Matthew J. Matasar Alison J. Moskowitz Craig H. Moskowitz Ar Source Type: research

Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium
Blood Cancer Journal, Published online: 16 July 2020; doi:10.1038/s41408-020-00341-yHost immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 16, 2020 Category: Hematology Authors: J. M. S ánchez-Maldonado D. Campa J. Springer J. Badiola Y. Niazi A. Mo ñiz-Díez F. Hern ández-Mohedo P. Gonz ález-Sierra R. Ter Horst A. Macauda S. Brezina C. Cunha M. Lackner M. A. L ópez-Nevot L. Fianchi L. Pagano E. L ópez-Fernández L. Potenza Source Type: research

B-cell maturation antigen expression across hematologic cancers: a systematic literature review
Blood Cancer Journal, Published online: 30 June 2020; doi:10.1038/s41408-020-0337-yB-cell maturation antigen expression across hematologic cancers: a systematic literature review (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 30, 2020 Category: Hematology Authors: Ahmet Dogan David Siegel Nguyet Tran Alan Fu Jessica Fowler Rajesh Belani Ola Landgren Source Type: research

Repurposing anthelmintic agents to eradicate resistant leukemia
Blood Cancer Journal, Published online: 26 June 2020; doi:10.1038/s41408-020-0339-9Repurposing anthelmintic agents to eradicate resistant leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 26, 2020 Category: Hematology Authors: Caterina Mezzatesta Liridon Abduli Anna Guinot Cornelia Eckert Denis Schewe Marketa Zaliova Luciana Vinti Blerim Marovca Yi-Chien Tsai Silvia Jenni Julia Aguade-Gorgorio Arend von Stackelberg Martin Schrappe Franco Locatelli Martin Stanulla Gunnar Cario J Source Type: research

The high cost of prescription drugs: causes and solutions
Blood Cancer Journal, Published online: 23 June 2020; doi:10.1038/s41408-020-0338-xThe high cost of prescription drugs: causes and solutions (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 23, 2020 Category: Hematology Authors: S. Vincent Rajkumar Source Type: research

Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns
Blood Cancer Journal, Published online: 19 June 2020; doi:10.1038/s41408-020-0336-zGenomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 19, 2020 Category: Hematology Authors: Carolina Schinke Eileen M. Boyle Cody Ashby Yan Wang Valeriy Lyzogubov Christopher Wardell Pingping Qu Antje Hoering Shayu Deshpande Katie Ryan Sharmilan Thanendrarajan Meera Mohan Naveen Yarlagadda Maliha Khan Samrat Roy Choudhury Maurizio Zangari Frits Source Type: research

CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma
Blood Cancer Journal, Published online: 17 June 2020; doi:10.1038/s41408-020-0335-0CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 17, 2020 Category: Hematology Authors: Rena R. Xian Yi Xie Lisa M. Haley Raluca Yonescu Aparna Pallavajjala Stefania Pittaluga Elaine S. Jaffe Amy S. Duffield Chad M. McCall Shereen M. F. Gheith Christopher D. Gocke Source Type: research

A population-based study of chronic neutrophilic leukemia in the United States
Blood Cancer Journal, Published online: 15 June 2020; doi:10.1038/s41408-020-0334-1A population-based study of chronic neutrophilic leukemia in the United States (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 15, 2020 Category: Hematology Authors: Gordon J. Ruan Caleb J. Smith Courtney Day William S. Harmsen Darci L. Zblewski Hassan Alkhateeb Kebede Begna Aref Al-Kali Mark R. Litzow William Hogan Natasha Szuber Naseema Gangat Mrinal S. Patnaik Animesh Pardanani Michelle A. Elliott Ayalew Tefferi Ro Source Type: research

Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia
Blood Cancer Journal, Published online: 11 June 2020; doi:10.1038/s41408-020-0332-3Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 11, 2020 Category: Hematology Authors: Albin Österroos My Bj örklund Anna Eriksson Johan Lindberg Christer Nilsson Sylvain Mareschal Mattias Rantalainen Henrik Gr önberg S ören Lehmann Source Type: research

Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study
Blood Cancer Journal, Published online: 08 June 2020; doi:10.1038/s41408-020-0333-2Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 8, 2020 Category: Hematology Authors: Giovanni Caocci Olga Mulas Isabella Capodanno Elisabetta Abruzzese Alessandra Iurlo Luigiana Luciano Francesco Albano Mario Annunziata Mario Tiribelli Massimiliano Bonifacio Sara Galimberti Fausto Castagnetti Nicola Sgherza Fabio Stagno Antonella Gozzini Source Type: research

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study
Blood Cancer Journal, Published online: 03 June 2020; doi:10.1038/s41408-020-0330-5A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 3, 2020 Category: Hematology Authors: A. Collignon M. A. Hospital C. Montersino F. Courtier A. Charbonnier C. Saillard E. D ’Incan B. Mohty A. Guille J. Adela ïde N. Carbuccia S. Garnier M. J. Mozziconacci C. Zemmour J. Pakradouni A. Restouin R. Castellano M. Chaffanet D. Birnbaum Y. Colle Source Type: research

Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment
Blood Cancer Journal, Published online: 01 June 2020; doi:10.1038/s41408-020-0331-4Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 1, 2020 Category: Hematology Authors: Priyanka Nair-Gupta Stephen I. Rudnick Leopoldo Luistro Melissa Smith Ronan McDaid Yingzhe Li Kodandaram Pillarisetti Jocelin Joseph Bradley Heidrich Kathryn Packman Ricardo Attar Fran çois Gaudet Source Type: research

Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients
Blood Cancer Journal, Published online: 29 May 2020; doi:10.1038/s41408-020-0327-0Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 29, 2020 Category: Hematology Authors: Hanno M. Witte Nadine Hertel Hartmut Merz Heinz-Wolfram Bernd Veronica Bernard Stephanie St ölting Nikolas von Bubnoff Alfred C. Feller Niklas Gebauer Source Type: research

Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
Blood Cancer Journal, Published online: 27 May 2020; doi:10.1038/s41408-020-0328-zAnalysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 27, 2020 Category: Hematology Authors: Jerome Paillassa Edouard Cornet Stephanie Noel Cecile Tomowiak Stephane Lepretre Sandrine Vaudaux Jehan Dupuis Alain Devidas Bertrand Joly Charlotte Petitdidier-Lionnet Stephanie Haiat Clara Mariette Catherine Thieblemont Didier Decaudin Patricia Validire Source Type: research

Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL
Blood Cancer Journal, Published online: 26 May 2020; doi:10.1038/s41408-020-0329-yUltra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 26, 2020 Category: Hematology Authors: Nicholas J. Short Hagop Kantarjian Rashmi Kanagal-Shamanna Koji Sasaki Farhad Ravandi Jorge Cortes Marina Konopleva Ghayas C. Issa Steven M. Kornblau Guillermo Garcia-Manero Rebecca Garris Jake Higgins Gabriel Pratt Lindsey N. Williams Charles C. Valentin Source Type: research

The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis
Blood Cancer Journal, Published online: 22 May 2020; doi:10.1038/s41408-020-0325-2The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 22, 2020 Category: Hematology Authors: Oliver C. Cohen Steven Law Helen J. Lachmann Faye Sharpley Sriram Ravichandran Shameem Mahmood Sajitha Sachchithanantham Carol J. Whelan Ana Martinez De Azcona Naharro Marianna Fontana Philip N. Hawkins Julian D. Gillmore Ashutosh D. Wechalekar Source Type: research

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma
Blood Cancer Journal, Published online: 22 May 2020; doi:10.1038/s41408-020-0322-5Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 22, 2020 Category: Hematology Authors: Victor Bob ée Fanny Drieux Vinciane Marchand Vincent Sater Liana Veresezan Jean-Michel Picquenot Pierre-Julien Viailly Marie-Delphine Lanic Mathieu Viennot Elodie Bohers Lucie Oberic Christiane Copie-Bergman Thierry Jo Molina Philippe Gaulard Corinne Hai Source Type: research

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
Blood Cancer Journal, Published online: 18 May 2020; doi:10.1038/s41408-020-0326-1Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 18, 2020 Category: Hematology Authors: Roberto Mina Angelo Belotti Maria Teresa Petrucci Renato Zambello Andrea Capra Giacomo Di Lullo Sonia Ronconi Norbert Pescosta Mariella Grasso Federico Monaco Claudia Cellini Marco Gobbi Stelvio Ballanti Paolo de Fabritiis Maria Letizia Mosca-Siez Monia M Source Type: research

Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome
Blood Cancer Journal, Published online: 14 May 2020; doi:10.1038/s41408-020-0324-3Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 14, 2020 Category: Hematology Authors: Andreas Willerslev-Olsen Terkild B. Buus Claudia Nastasi Edda Bl ümel Maria Gluud Charlotte M. Bonefeld Carsten Geisler Lise M. Lindahl Maarten Vermeer Mariusz A. Wasik Lars Iversen J ürgen C. Becker Mads Hald Andersen Lise M. R. Gjerdrum Ivan V. Litvin Source Type: research

Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century
Blood Cancer Journal, Published online: 13 May 2020; doi:10.1038/s41408-020-0323-4Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 13, 2020 Category: Hematology Authors: Dianne Pulte Lina Jansen Hermann Brenner Source Type: research

“Direct to Drug” screening as a precision medicine tool in multiple myeloma
Blood Cancer Journal, Published online: 11 May 2020; doi:10.1038/s41408-020-0320-7“Direct to Drug” screening as a precision medicine tool in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 11, 2020 Category: Hematology Authors: Cecilia Bonolo de Campos Nathalie Meurice Joachim L. Petit Alysia N. Polito Yuan Xiao Zhu Panwen Wang Laura A. Bruins Xuewei Wang Ilsel D. Lopez Armenta Susie A. Darvish Greg J. Ahmann Kimberly J. Henderson Shulan Tian Jonas J. Kruse William M. Stewart Je Source Type: research

Venetoclax for the treatment of translocation (11;14) AL amyloidosis
Blood Cancer Journal, Published online: 11 May 2020; doi:10.1038/s41408-020-0321-6Venetoclax for the treatment of translocation (11;14) AL amyloidosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 11, 2020 Category: Hematology Authors: M. Hasib Sidiqi Abdullah S. Al Saleh Nelson Leung Dragan Jevremovic Mohammed A. Aljama Wilson I. Gonsalves Francis K. Buadi Taxiarchis V. Kourelis Rahma Warsame Eli Muchtar Miriam A. Hobbs Martha Q. Lacy David Dingli Ronald S. Go Suzanne R. Hayman S. Vinc Source Type: research

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
Blood Cancer Journal, Published online: 11 May 2020; doi:10.1038/s41408-020-0311-8Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 11, 2020 Category: Hematology Authors: Brian G. M. Durie Antje Hoering Rachael Sexton Muneer H. Abidi Joshua Epstein S. Vincent Rajkumar Angela Dispenzieri Stephen P. Kahanic Mohan C. Thakuri Frederic J. Reu Christopher M. Reynolds Robert Z. Orlowski Bart Barlogie Source Type: research

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
Blood Cancer Journal, Published online: 06 May 2020; doi:10.1038/s41408-020-0319-0The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied? (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 6, 2020 Category: Hematology Authors: M. Hasib Sidiqi Mohammed Aljama Shaji K. Kumar Dragan Jevremovic Francis K. Buadi Rahma Warsame Martha Q. Lacy David Dingli Wilson I. Gonsalves Amie L. Fonder Miriam A. Hobbs Yi Lisa Hwa Prashant Kapoor Taxiarchis Kourelis Nelson Leung Eli Muchtar John A. Source Type: research

NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies
Blood Cancer Journal, Published online: 05 May 2020; doi:10.1038/s41408-020-0313-6NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 5, 2020 Category: Hematology Authors: Nikhil Patkar Prasanna Bhanshe Sweta Rajpal Swapnali Joshi Shruti Chaudhary Gaurav Chatterjee Prashant Tembhare Chetan Dhamne Maya Prasad Nirmalya Roy Moulik Dhanalaxmi Shetty Anant Gokarn Avinash Bonda Lingaraj Nayak Sachin Punatkar Bhausaheb Bagal Manju Source Type: research

Parental origin of monosomic chromosomes in near-haploid acute lymphoblastic leukemia
Blood Cancer Journal, Published online: 05 May 2020; doi:10.1038/s41408-020-0317-2Parental origin of monosomic chromosomes in near-haploid acute lymphoblastic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 5, 2020 Category: Hematology Authors: Kristina B. Lundin-Str öm Kristoffer Str öm Andrea Biloglav Gisela Barbany Mikael Behrendtz Anders Castor Linda Olsson-Arvidsson Bertil Johansson Source Type: research

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia
Blood Cancer Journal, Published online: 04 May 2020; doi:10.1038/s41408-020-0318-1Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 4, 2020 Category: Hematology Authors: Iman Abou Dalle Ahmad Ghorab Keyur Patel Xuemei Wang Hyunsoo Hwang Jorge Cortes Ghayas C. Issa Fevzi Yalniz Koji Sasaki Dai Chihara Allyson Price Tapan Kadia Naveen Pemmaraju Naval Daver Courtney DiNardo Farhad Ravandi Hagop M. Kantarjian Gautam Borthakur Source Type: research

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up
Blood Cancer Journal, Published online: 04 May 2020; doi:10.1038/s41408-020-0312-7Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 4, 2020 Category: Hematology Authors: Hui Zhou Zijun Y. Xu-Monette Ling Xiao Paolo Strati Fredrick B. Hagemeister Yizi He Huan Chen Yajun Li Ganiraju C. Manyam Yong Li Santiago Montes-Moreno Miguel A. Piris Ken H. Young Source Type: research

Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype
Blood Cancer Journal, Published online: 04 May 2020; doi:10.1038/s41408-020-0316-3Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 4, 2020 Category: Hematology Authors: Bachar Samra Guillaume Richard-Carpentier Tapan M. Kadia Farhad Ravandi Naval Daver Courtney D. DiNardo Ghayas C. Issa Prithviraj Bose Marina Y. Konopleva Musa Yilmaz Maro Ohanian Gautam Borthakur Guillermo Garcia-Manero Sherry Pierce Jorge E. Cortes Hago Source Type: research

Impact of mitochondrial DNA mutations in multiple myeloma
Blood Cancer Journal, Published online: 01 May 2020; doi:10.1038/s41408-020-0315-4Impact of mitochondrial DNA mutations in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 1, 2020 Category: Hematology Authors: Phuc H. Hoang Alex J. Cornish Daniel Chubb Graham Jackson Martin Kaiser Richard S. Houlston Source Type: research

DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma
Blood Cancer Journal, Published online: 28 April 2020; doi:10.1038/s41408-020-0310-9DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 28, 2020 Category: Hematology Authors: Zahra Haider Mattias Landfors Irina Golovleva Martin Erlanson Kjeld Schmiegelow Trond Fl ægstad Jukka Kanerva Ulrika Nor én-Nyström Magnus Hultdin Sofie Degerman Source Type: research

Dissecting racial disparities in multiple myeloma—clues from differential immunoglobulin levels
Blood Cancer Journal, Published online: 28 April 2020; doi:10.1038/s41408-020-0314-5Dissecting racial disparities in multiple myeloma—clues from differential immunoglobulin levels (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 28, 2020 Category: Hematology Authors: C. M. Bunce M. T. Drayson Source Type: research

DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies
Blood Cancer Journal, Published online: 28 April 2020; doi:10.1038/s41408-020-0292-7DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 28, 2020 Category: Hematology Authors: Simone C. Oostindie Hilma J. van der Horst Laurens P. Kil Kristin Strumane Marije B. Overdijk Edward N. van den Brink Jeroen H. N. van den Brakel Hendrik J. Rademaker Berris van Kessel Juliette van den Noort Martine E. D. Chamuleau Tuna Mutis Margaret A. Source Type: research

A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics
Blood Cancer Journal, Published online: 24 April 2020; doi:10.1038/s41408-020-0308-3A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 24, 2020 Category: Hematology Authors: Ricardo S ánchez Jordi Ribera Mireia Morgades Rosa Ayala Esther Onecha Yanira Ruiz-Heredia Alexandra Ju árez-Rufián Rodrigo de Nicol ás Jos é Sánchez-Pina Susana Vives Lurdes Zamora Santiago Mercadal Rosa Coll Marta Cervera Olga Garc ía Josep-Maria Source Type: research